STO:BONEX

Bonesupport Holding AB (publ) · STO · Healthcare · SEK · FY for 2025

Figures on this page computed 2026-11-08 12:41 UTC

Last close

n/aSEK

Market data

  • 148.4xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • computed
    • Computed from the filing for 2025
  • 39.4%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 12.1%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 18.4%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.01Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • computed

Five bars, one line

lens 7 of 9
3.03x
-4.58x
-4.12x
0.34x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales3.03x

    Its own average over 10 years, 387.3M.

  • Profit-4.58x

    Its own average over 10 years, -31.1M.

  • Free cash flow-4.12x

    Its own average over 10 years, -52.5M.

  • Debt0.34x

    Its own average over 9 years, 34.6M.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at -4.58 times.

Sales is 3.03 times its own 10-year average; Profit is -4.58 times its own 10-year average; Free cash flow is -4.12 times its own 10-year average; Debt is 0.34 times its own 9-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average3.03
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SEK
  • Profit against its own 10-year average-4.58
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SEK
  • Free cash flow against its own 10-year average-4.12
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SEK
  • Debt against its own 9-year average0.34
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SEK
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    SEK

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.